| Cabozantinib | IC50 | 7.0 [1] |
| Crizotinib | IC50 | 1.0 [1], 100.0 [2], 294.0 [3], 300.0 [4] |
| Bosutinib | IC50 | 174.0 [1], 340.0 [2], 560.0 [3] |
| Bemcentinib | IC50 | 0.7 [1], 14.0 [2], 30.0 [3] |
| 4-[2-(Butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 1.65 [1], 14.0 [2], 122.0 [3] |
| 1-[(trans-4-Aminocyclohexyl)methyl]-N-Butyl-3-(4-Fluorophenyl)-1h-Pyrazolo[3,4-D]pyrimidin-6-Amine | IC50 | 37.0 [1] |
| 4-[5-[4-[(4-Methyl-1,4-diazepan-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 12.1 [1], 80.0 [2], 859.0 [3] |
| Staurosporine | IC50 | 3.0 [1], 40.0 [2] |
| Sunitinib | IC50 | 9.0 [1] |
| Foretinib | IC50 | 11.0 [1], 100.0 [2] |
| Bms-777607 | IC50 | 1.1 [1] |
| Merestinib | IC50 | 2.0 [1], 11.0 [2] |
| JNJ-28312141 free base | IC50 | 12.0 [1], 2600.0 [2] |
| c-FMS inhibitor | IC50 | 6.4 [1] |
| CID 46194178 | IC50 | 10.0 [1], 500.0 [2] |
| Exelixis | IC50 | 7.0 [1], 42.0 [2] |
| CID 49870909 | IC50 | 7.0 [1], 56.0 [2] |
| CID 46870258 | IC50 | 58.0 [1], 1000.0 [2] |
| 1-[(4-Aminocyclohexyl)methyl]-N-methyl-3-(4-piperazin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 14.0 [1], 140.0 [2] |
| 6-[6-Amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-3-yl]-1'-methylspiro[1H-indole-3,4'-piperidine]-2-one | IC50 | 28.9 [1], 300000.0 [2] |
| 1-[(4-Aminocyclohexyl)methyl]-N-methyl-3-phenylpyrazolo[3,4-d]pyrimidin-6-amine | IC50 | 81.0 [1], 370.0 [2] |
| 4-[[6-(Methylamino)-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl]methyl]cyclohexan-1-ol | IC50 | 83.0 [1], 190.0 [2] |
| Quercetin | IC50 | 960.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| Sotrastaurin | IC50 | 9100.0 [1] |
| Nvp-aew541 | IC50 | 10000.0 [1] |
| CID 53469448 | IC50 | 2705.0 [1] |
| Gilteritinib | IC50 | 1.0 [1] |
| Amuvatinib | IC50 | 1000.0 [1] |
| 1-(3-Chlorophenyl)-3-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)ethyl]-1,3-Thiazol-2-Yl}urea | IC50 | 84.0 [1] |
| Norlichexanthone | IC50 | 100000.0 [1] |
| TP-0903 | IC50 | 27.0 [1] |
| (4S,6Z,9S,10S)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dione | IC50 | 10000.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| CID 44155856 | IC50 | 3.0 [1] |
| Unii-T7755XP5Y6 | IC50 | 85.0 [1] |
| 4-[[2-(Butylamino)-5-[5-(morpholin-4-ylmethyl)pyridin-2-yl]pyrimidin-4-yl]amino]cyclohexan-1-ol | IC50 | 270.0 [1] |
| R428 (BGB324; Bemcentinib) | IC50 | 14.0 [1] |
| CID 56847486 | IC50 | 19.0 [1] |
| 2,3,6,8-Tetrahydroxy-1-methylxanthone | IC50 | 6600.0 [1] |
| Epicoccolide B | IC50 | 220.0 [1] |
| 4-(5-Phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid | IC50 | 182.0 [1] |
| 3-N-[4-(4-Morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine | Ki | 40.0 [1] |
| Astrogorgiadiol B | IC50 | 16900.0 [1] |
| 2-(Butylamino)-4-[(4-hydroxycyclohexyl)amino]-N-[(4-imidazol-1-ylphenyl)methyl]pyrimidine-5-carboxamide | IC50 | 360.0 [1] |
| (1S,9R)-5,6,12,13,14-Pentahydroxy-4,11-dimethyl-16-oxo-8,17-dioxatetracyclo[7.7.1.02,7.010,15]heptadeca-2(7),3,5,10,12,14-hexaene-3-carbaldehyde | IC50 | 160.0 [1] |
| (1R,3As,4S,5R,7aR)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,3a,4,5,6,7-octahydroinden-5-ol | IC50 | 100000.0 [1] |
| Calicoferol B | IC50 | 100000.0 [1] |
| 6,6-Dimethyl-8-[1-(oxan-4-ylmethyl)piperidin-4-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile | IC50 | 170.0 [1] |
| Calicoferol E | IC50 | 32600.0 [1] |
| 2-Amino-N-[3-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]phenyl]acetamide | IC50 | 1000.0 [1] |
| 1-[5-Amino-4-(3,4-dichlorophenyl)-3-methylpyrazol-1-yl]ethanone | IC50 | 100000.0 [1] |
| Ripk1-IN-7 | IC50 | 35.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| 8-(2,3-Dihydro-1H-inden-5-yl)-2-[4-(4-methylpiperazin-1-yl)anilino]-5-oxopyrido[2,3-d]pyrimidine-6-carboxamide | IC50 | 300.0 [1] |
| 8-(2,3-Dihydro-1H-inden-5-yl)-2-[4-[2-(4-methylpiperazin-1-yl)ethyl]anilino]-5-oxopyrido[2,3-d]pyrimidine-6-carboxamide | IC50 | 500.0 [1] |
| Methyl 1H-pyrrolo[2,3-b]pyridine-3-carboxylate | IC50 | 10000.0 [1] |
| [6-Chloro-4-methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate | IC50 | 50000.0 [1] |
| 1-(2,6-Dichlorophenyl)-3-(6-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-4-yl)urea | IC50 | 10000.0 [1] |
| 3-Hydroxy-N-(2-hydroxy-1-methyl-ethyl)-5-(4-phenylamino-phenylamino)-isothiazole-4-carboxamidine | IC50 | 389.0 [1] |
| 3-(4-(1H-Tetrazol-5-yl)phenyl)-5-phenyl-1H-pyrrolo[2,3-b]pyridine | IC50 | 524.0 [1] |
| N-[4-(6,7-Dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxamide | IC50 | 10000.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| 7,8-Dichloro-9-methyl-1-oxospiro[2,4-dihydropyrido[3,4-b]indole-3,4'-piperidine]-4-carbonitrile | IC50 | 10000.0 [1] |
| N-[5-[(Z)-(5-Fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-yl]-3-(4-methylpiperazin-1-yl)propanamide | Ki | 63.0 [1] |
| 3,5-Diphenyl-1H-pyrrolo[2,3-b]pyridine | IC50 | 4060.0 [1] |
| N-(7-Methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide | IC50 | 50000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 4-(Cyclopentylamino)-2-[(2-methoxyphenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 5700.0 [1] |
| 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 3200.0 [1] |
| 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide | IC50 | 3990.0 [1] |
| 6-(6-Fluoroindol-1-yl)-2-[2-[7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyethyl]pyridazin-3-one | IC50 | 1000.0 [1] |
| (7S)-7-Amino-N-[(4-fluorophenyl)methyl]-8-oxo-2,9,16,18,21-pentazabicyclo[15.3.1]henicosa-1(21),17,19-triene-20-carboxamide | IC50 | 120.0 [1] |
| 5-[1-(Cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine | IC50 | 448.0 [1] |
| (8S,16S)-3,16-Dihydroxy-9,10-seco-1,3,5(10)-cholestatrien-9-one | IC50 | 100000.0 [1] |
| Calicoferol A | IC50 | 14700.0 [1] |
| (1R,3As,4S,7aR)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,3a,4,6,7-hexahydro-1H-inden-5-one | IC50 | 20200.0 [1] |
| 5-Phenyl-1H-pyrrolo[2,3-b]pyridine | IC50 | 10000.0 [1] |
| Methyl 3-[[(1R,2S,4aR,8aS)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl]-4,5-dihydroxybenzoate | IC50 | 13100.0 [1] |
| N-(1H-Pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide | IC50 | 10000.0 [1] |
| N-Pyridin-3-yl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide | IC50 | 10000.0 [1] |
| 5-Cyano-N-[2-(cyclohexen-1-yl)-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]phenyl]-1H-imidazole-2-carboxamide | IC50 | 16.0 [1] |
| 5-Cyano-N-[2-(cyclohexen-1-yl)-4-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]phenyl]-1H-imidazole-2-carboxamide | IC50 | 6.0 [1] |
| 4-[5-[4-(Morpholin-4-ylmethyl)phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 218.0 [1] |
| 4-[5-[3-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 213.0 [1] |
| 4-[2-(Butylamino)-5-[4-(piperidin-4-ylamino)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 42.0 [1] |
| 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2R)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 560.0 [1] |
| 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-(pentan-2-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 125.0 [1] |
| 4-[2-[[(2S)-Heptan-2-yl]amino]-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 81.0 [1] |
| 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 118.0 [1] |
| 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2S)-1,1,1-trifluoropentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 11037.0 [1] |
| 4-[2-(2-Methylbutylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 100.0 [1] |
| 4-[2-(2-Ethylbutylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 206.0 [1] |
| 4-[5-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-[[(2R)-1,1,1-trifluoropentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 2543.0 [1] |
| 4-[2-[[(2S)-Hexan-2-yl]amino]-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 64.0 [1] |
| 4-[5-[4-[[2-(Diethylamino)ethylamino]methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 80.0 [1] |
| 4-[2-[[(2S)-Pentan-2-yl]amino]-5-[4-(piperidin-4-ylamino)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 206.0 [1] |
| 4-[5-[4-(Cyclohexylamino)phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 7356.0 [1] |
| 4-[5-[4-(7-Azabicyclo[2.2.1]heptan-7-ylmethyl)phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 84.0 [1] |
| 4-[5-[2-Fluoro-4-(4-methylpiperazin-1-yl)sulfonylphenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 191.0 [1] |